India MCA Insolvency Liquidation Filings — September 26, 2026
The India MCA Insolvency & Restructuring Monitor for September 26, 2026, reveals a bifurcated landscape: one high-quality corporate restructuring via NCLT-approved amalgamation (Dabur India/Sesa Care) and one contested insolvency-adjacent proceeding (Cemantic Infra-Tech) under oppression/mismanagement sections. The Dabur-Sesa Care scheme, approved by 97.74% of equity shareholders and unanimously by unsecured creditors, signals strong stakeholder confidence and a strategic push into the premium ayurvedic hair oil segment, leveraging Dabur's distribution network. In contrast, Cemantic Infra-Tech faces a shareholder petition under Sections 241/242/244 of the Companies Act, with the NCLT denying interim relief and adjourning to November 25, 2026—a temporary reprieve but a clear governance red flag. No period-over-period financial comparisons, insider trading, capital allocation, or forward-looking guidance data were available in the enriched filings, limiting trend analysis. The key portfolio-level pattern is the divergence between consensual restructuring (Dabur) and contested governance disputes (Cemantic), with the former offering a clear value-accretive catalyst and the latter posing material legal overhang. The most critical market implication is the potential for Dabur to capture market share in the ₹5,000+ crore ayurvedic hair oil market through Sesa's premium positioning, while Cemantic's unresolved governance issues could deter institutional investors.